Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Eyal, Jacob"'
Autor:
Jair Bar, Raya Leibowitz, Niels Reinmuth, Astrid Ammendola, Eyal Jacob, Mor Moskovitz, Adva Levy-Barda, Michal Lotem, Rivka Katsenelson, Abed Agbarya, Mahmoud Abu-Amna, Maya Gottfried, Tatiana Harkovsky, Ido Wolf, Ella Tepper, Gil Loewenthal, Ben Yellin, Yehuda Brody, Nili Dahan, Maya Yanko, Coren Lahav, Michal Harel, Shani Raveh Shoval, Yehonatan Elon, Itamar Sela, Adam P. Dicker, Yuval Shaked
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionImmune checkpoint inhibitors have made a paradigm shift in the treatment of non-small cell lung cancer (NSCLC). However, clinical response varies widely and robust predictive biomarkers for patient stratification are lacking. Here, we cha
Externí odkaz:
https://doaj.org/article/926af04f4d0440e18244af89ddf7f699
Autor:
David P Carbone, Jair Bar, Alona Zer, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Ofer Sharon, Nili Dahan, Itamar Sela, Yehonatan Elon, Galit Yahalom, Iris Kamer, Adam P Dicker, Shani Raveh Shoval
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/f1f33c7a45134017899795d4e2e594c1
Autor:
David Carbone, Jair Bar, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Adam Dicker, Ofer Sharon, Itamar Sela, Yehonatan Elon, Galit Yahalom, Iris Kamer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/bf502c926d9248b1889fa475138754af
Autor:
Ziv Raviv, Yuval Shaked, Michal Harel, Eyal Jacob, Irina Khononov, Ella Fremder, Nili Dahan, Boris Krastev
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Immune checkpoint inhibitors (ICIs) have made a paradigm shift in clinical oncology due to unprecedented long-term remissions. However, only a small proportion of patients respond to ICI therapy. It is, therefore, essential to understand t
Externí odkaz:
https://doaj.org/article/bff6b185724a475bb156ddba2d7316bc
Autor:
Mario Sznol, Ruth Halaban, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Eran Issler, Haim Bar, Adam Dicker, Ofer Sharon, Antonietta Bacchiocchi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5b561c7de1df4983af5ef64e4da9a888
Autor:
Yuval Shaked, Jair Bar, Michal Harel, Itamar Sela, Yehonatan Elon, Coren Lahav, Ofer Sharon, Eyal Jacob, Iris Kamer, Galit Yahalom, David P. Carbone, Adam P. Dicker
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by shifting the focus from the tumor to the immune system of the host. Despite durable response to ICIs, only a small proportion of non-small lung cancer (NSCLC) patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f119d28deb149f9539621fdbd5810a
https://doaj.org/article/bf502c926d9248b1889fa475138754af
https://doaj.org/article/bf502c926d9248b1889fa475138754af
Publikováno v:
The Journal of Cell Biology, 1993 Jan 01. 120(2), 513-521.
Externí odkaz:
https://www.jstor.org/stable/1615581
Publikováno v:
The Journal of Cell Biology, 1992 Jan 01. 116(1), 209-217.
Externí odkaz:
https://www.jstor.org/stable/1614941
Autor:
Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, Itamar Sela, Yehonatan Elon, Shani Raveh Shoval, Galit Yahalom, Iris Kamer, Alona Zer, Ofer Sharon, David P Carbone, Adam P Dicker, Jair Bar, Yuval Shaked
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004582
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized the cancer therapy landscape due to long-term benefits in patients with advanced metastatic disease. However, robust predictive biomarkers for response are still lacking and treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f87e28c46069c910a3a470a9469048a
https://doi.org/10.1136/jitc-2022-004582
https://doi.org/10.1136/jitc-2022-004582
Autor:
Michal Harel, Yehonatan Elon, Hovav Nechushtan, Jair Bar, Itamar Sela, Alona Zer, Yuval Shaked, Maya Gottfried, M. Abu-Amana, Adam P. Dicker, Ofer Sharon, Rivka Katzenelson, Ido Wolf, Iris Kamer, Eyal Jacob, Abed Agbarya, Coren Lahav, Galit Yahalom, M.T. Moskovits
Publikováno v:
Annals of Oncology. 32:S388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f94be3c5e7cd99a5b41f365af05ca5e5
https://doi.org/10.1016/j.annonc.2021.08.354
https://doi.org/10.1016/j.annonc.2021.08.354